Pinsent Masons advises BP on its first investment in artificial intelligence in China

21 Jan 2020 | 05:21 pm |

International law firm Pinsent Masons has advised global energy company BP on its investment in energy management tech specialist R&B

This is the first BP Venture investment in the field of artificial intelligence (AI) technology in China. R&B's energy management systems are designed to predict, control and improve a building’s energy use, supporting BP Alternative Energy’s focus on low-carbon power, storage and digital energy value chain.

Pinsent Masons advised BP throughout the lifecycle of the deal, from due diligence to the drafting, reviewing and negotiation of investment transaction documentation as well as completion.

Wei Liu, Corporate Transaction Services partner of Pinsent Masons said, "Energy saving and emission reduction become a reality when AI, energy and capital are combined together. This is a project with unlimited potential and high social value. We're proud to have participated in and contributed to the project of BP's investment in R&B."

BP’s investment in R&B was supported by a cross-office team of Pinsent Masons, with involvement across the Shanghai and Hong Kong offices. The team included lead partner Wei Liu, legal director Michael Lin and Junior counsel Xiaowen Jiang, and legal director Norman Leung. 

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons appointed to UK Government Trade Law Panel

Multinational law firm Pinsent Masons has been appointed to the UK Government's new Trade Law Panel in an international consortium with BakerHostetler in the USA, and Fasken in Canada, to advise on international trade law disputes.

Pinsent Masons wins Belt and Road Deal of the Year and Overseas Deal of the Year awards at the China Business Law Awards

Multinational law firm Pinsent Masons has won Belt and Road Deal of the Year and Overseas Deal of the Year awards for the firms work on the Red Sea Tourism Mega Project in Saudi Arabia and Mexico City's Subway Line Construction Project respectively.

Pinsent Masons appoints infrastructure partner in Perth

Multinational law firm Pinsent Masons has hired infrastructure partner David Ulbrick to its team in the Perth office.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts